Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment
Observational Study
[키워드] all-cause mortality
Alpha
Analysis
Anemia
antiviral medication
benefit
center
clinical condition
Cohort
collected
Comorbidity
COPD
coronavirus disease
Course
covariates
COVID-19
COVID-19 pandemic
COVID-19 patient
diabete
effective
Efficacy
epidemiological situation
Frequency
greater
group
hospitalized patients
Hungary
Inpatient
lack
male
men
Mortality
multiple comorbidities
multivariate
Observational cohort study
outcome
parenchymal
participant
Patient
performed
Primary outcome
RDV
real-world data
receiving
Remdesivir
retrospective
risk reduction
Significant
significantly lower
significantly more
specific patient groups
Standard of care
supplementary oxygen
survival
Treatment
Treatment protocol
treatment regimen
university
Vaccinations
variant
[DOI] 10.7189/jogh.12.05031 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.7189/jogh.12.05031 PMC 바로가기 [Article Type] Observational Study